Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-073691
Filing Date
2014-02-28
Accepted
2014-02-27 18:55:26
Documents
15
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d644983d10k.htm 10-K 1201540
2 EX-23.1 d644983dex231.htm EX-23.1 1390
3 EX-31.1 d644983dex311.htm EX-31.1 5890
4 EX-31.2 d644983dex312.htm EX-31.2 5891
5 EX-32.1 d644983dex321.htm EX-32.1 3782
12 GRAPHIC g644983g30z92.jpg GRAPHIC 52359
13 GRAPHIC g644983g33c16.jpg GRAPHIC 45462
14 GRAPHIC g644983g45s11.jpg GRAPHIC 41506
15 GRAPHIC g644983g50p56.jpg GRAPHIC 44621
  Complete submission text file 0001193125-14-073691.txt   7577196

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT epzm-20131231.xml EX-101.INS 995849
7 XBRL TAXONOMY EXTENSION SCHEMA epzm-20131231.xsd EX-101.SCH 60589
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20131231_cal.xml EX-101.CAL 71071
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20131231_def.xml EX-101.DEF 174877
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20131231_lab.xml EX-101.LAB 494430
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20131231_pre.xml EX-101.PRE 351362
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

EIN.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35945 | Film No.: 14650907
SIC: 2834 Pharmaceutical Preparations